OKG-0303

N/A

Report date: 2025/09/29 14:28:14

First In Class

Base Information

Drug NameOKG-0303

Drug Alias NameOKG-0303

ClassificationBiologics > Protein drugs > Enzyme

Mechanisms of ActionApoptosis stimulantsProtein synthesis inhibitorsDeoxyribonucleases replacements +[4]

TargetsDeoxyribonucleasesAlpha adrenergic receptor

Therapy Area/IndicationsConjunctivitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsYes

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesOkogen Inc

China Registration ClassN/A

Active CompaniesOkogen Inc

Inactive CompaniesN/A

Active IndicationsConjunctivitis

Inactive IndicationsN/A

ATC CodeN/A